Figure 1
![Main bioactive components of N. sativa: (A) carvacrol (5-isopropyl-2-methylphenol; National Center for Biotechnology Information. PubChem Database compound identification number [CID] 10364), (B) 4-cymene (4-isopropyltoluene; CID 7463), (C) thymoquinone (4-cymene-2,5-dione; CID 10281), (D) nigellidine (CID 136828302), (E) nigellicine (CID 11402337), and (F) α-hederin (CID 73296).](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/647067f983f1392090d68d7d/j_abm-2020-0020_fig_001.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Credential=ASIA6AP2G7AKG2EA3BVD%2F20260128%2Feu-central-1%2Fs3%2Faws4_request&X-Amz-Date=20260128T022532Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjEJb%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaDGV1LWNlbnRyYWwtMSJHMEUCIEK4uVx1bslmUvYJLfh0wDgsT208UWnS8%2FcTzSJJFZZAAiEAzjjqN%2F30wX9fIhTE5dJiYX9g2Hua2lTSL1FHb%2F%2BGTbAqvQUIXxACGgw5NjMxMzQyODk5NDAiDPEo2k78i478vwM0HiqaBScMmP6fa4OaP34dgightF5aNWmlLPEEzsjyVCZEy2JTsj57IZX1%2BjLpKeZOUNQbCvmZ3S6qrgRylVD17yQnw9LzEF6ys%2FRyydYm%2F24tcW9k7uX7lv9TWJfV9qF2m8V9OeS0e6lndYEGN5EoFhx%2Bh60SHf%2F29EAtN1lIccHTwXXx0K20B%2BBzC4zJLns0Wu7GPIumiFimtlpkQMHPgvEXI%2Fm764f12YPzO3GdtdwRXBb4ADkH18YRhyQ5Yd6NcXD%2B%2F6Kdfyc4SZPk6otW%2Bh5%2BNKXmd%2BQUAFRMMheP65MvAYZwWh7rEbFzTIxUqiDJp7Rcrrt4%2B1liefhlBj78b9zOh0eJLIMpPWFp9%2B0r07yGEzBZVUQqrP678vFGUydDEf3irN1YaHBSmq5mOUzYYIzvHNP44lNe%2FCmAqwym5dEOk5rHFPkqVtAlGJdXDLLmVmEPXwXWkFTFu1Mpb7eC3jV%2F5FE6gqr%2FZAhMNR9c21qq%2FvtjmqHHWiKIE%2FppUfjNhZ1Ja45%2B6A4GvRwXeKTzEiQKd2xeK2uEIQHlHj410sQrpiKHek9XCsw149mmbw8n3kIQl10xg3a2p6s5s7w4lKBSaL9PCtvpR564yO%2Fh3zqvRoXTfZZjh1mJI2oni2J4QwvWJL4fxOGF6wKh3HG4qUgkvgEVEcLiPu6uTN65S0rT07CZOQ%2BvvtYMiPFdT%2BdA3Dx8ohmVe2OSaNsFLDBgt5ZQAYgR7ut9BdH66SfXnoKv03bkqWlsXt4GSTY210NzR5Ku%2Bl8FYE%2BJGi4CoAhPM0b2rmRYs2SiJJbjwunTAR7S8VlnFAfc9ajNY7E5qRK1O1Hz2Z1XFjcfPHLMifUiidQMF2dxU8Sl9egriz67vCGbFyJ5wRYvNZMOhmRs1TDF6uTLBjqxAZF6j%2B8RVRqAJzxKNf4eCkEyyJJ279uHylxdqzWoUZgZlyno2ld8%2FDxebiXgHIB0lSyLjiH13FGUlHxKPMcadi7hF4ujAJzy7f9gt2tF879%2F22uymnGybnutsL9IChcto8PTCBw6IJ1JYtEzlMPZL9NxexMqbuAw%2Bz7LZLDVhnP1W41VO5ssGb5gJvWp7whhay1OS8i2Alq0efLINvX4ZtFh1jMx6zaxkOh%2FNT2JWepXFg%3D%3D&X-Amz-Signature=d7f0b0b2a8cc23f3b8087164dcf53ba24001c10d0dc6488fa3d2b06d31376f3c&X-Amz-SignedHeaders=host&x-amz-checksum-mode=ENABLED&x-id=GetObject)
Figure 2

Subacute toxicity of Nigella sativa in animal studies
| Substance/dose | Animals used | Exposure period | Observation period | Main results | Reference |
|---|---|---|---|---|---|
| N. sativa seeds AE 10 mL/kg, p.o. | Male Sprague Dawley rats | 14 days | 30 days | ↑ Serum γ-GT and ALT levels. Unchanged serum ALP levels and histopathological examinations | [63] |
| N. sativa seed oil 10 mL/kg, p.o. | Rats | 48 h | Not specified | No toxicity | [53] |
| Mice | |||||
| N. sativa seeds AE, ME, and CE 6 g/kg, p.o | Both sexes of young virgin mice | 14 days | Same 14 days | No toxicity wide margin of safety | [4] |
| N. sativa powder 90, 180, 360, and 540 mg/kg, locally | Normal adult male albino rats | 1, 2, and 4 weeks | Same 4 weeks | Transient alterations in both anticoagulant and coagulant functions | [54] |
| N. sativa powder 0.01, 0.1, and 1 g/kg/day, p.o | Male Sprague Dawley rats | 28 days | Same 28 days | No toxicity | [64] |
| N. sativa AE 2, 6.4, 21, 33, and 60 g/kg, orally), p.o | Mus musculus | 6 weeks | Same 6 weeks | 21 g/kg: hepatotoxic 60 g/kg: high mortality | [65] |
| mice | |||||
| BSH 100, 500, 1,000, and 2,000 mg/kg, p.o | Male Sprague Dawley rats | 14 days | 28 days | No toxicity | [66] |
Cytotoxic and genotoxic properties of Nigella sativa in vitro
| Substance | Concentration period | Period | Cell type | Main results | Reference |
|---|---|---|---|---|---|
| N. sativa oil | 0.25, 0.5, and 1 μg/mL | 95 h | Gingival fibroblasts | No cytotoxicity | [67] |
| N. sativa EE | 0–2 mg/mL | 24 h | Rat L6 muscle cell line | EC50 >2,000 μg/mL against L6myc cell lines | [68] |
| N. sativa EE | 100, 500, and 1,000 μg/mL | 48 h | Isolated rat splenocytes | Cytotoxic effects at 500 and 1,000 μg/mL | [57] |
| N. sativa EO and ME, PE, CE, AE, and ether extract | 10, 100, and 1,000 μg/mL | 24 h | BSL | Higher toxicity by chloroform and petroleum ether extracts. | [69] |
| N. sativa seed VO | 500, 250, 125, and 62.5 μg/mL | Not specified | SCL, SCL-6, SCL-37′6, NUGC-4, Kato-3, 3T6 | LC50 SCL 155.02 μg/mL | [70] |
| N. sativa PE and AE | 670 μg/mL | 24 h | HL60 | IC50 PE 654 μg/mL | [71] |
| N. sativa EO | 100 mg/mL | 24 h | Huh7 human cells | No cytotoxicity | [72] |
| N. sativa seed oil | 50–500 μg/mL | U-1242, U251, U-87, U-373, A172 and SNB19 | IC50 260 μg/mL | [58] | |
| AE of N. sativa | 0.5, 1, 4, 8, 9, and 18 mg/mL | Human C3A cells | Positive micronucleus test extract from Setta | [73] | |
| N. sativa seed ME, NE, and CE | 2, 2.25, 2.5, 2.75, and 3 μg/mL of methanolic, n-hexane. | 24 h | HeLa cells | IC50 methanolic: 2.28 μg/mL | [74] |
| N. sativa AE | 79.5 μg/mL | 48 h | F 344 hepatocytes treated with MNNG | ↑ Chromosomal aberrations | [59] |
Acute toxicity of Nigella sativa in animal studies
| Substance/dose | Animals used | Observation period | LD50 | Reference |
|---|---|---|---|---|
| N. sativa seed VO, FO, and AE, i.p. | SWR mice | 24 h | AE: 3,020 mg/kg | [51] |
| N. sativa seed FO 0.25, 0.5, 1, 2, 3, 4, and 6 mL/kg, i.p. | Both sexes of mice | 15 days | 2.06 mL/kg | [49] |
| N. sativa seed FO 10, 15, 20, 25, 30, 40, and 50 mL/kg, p.o | 28.8 mL/kg | |||
| N. sativa seeds AE, ME and CE 6, 9, 14 and 21 g/kg, p.o. | Both sexes of young virgin mice | 7 days | No mortality | [4] |
| N. sativa EO 0.2, 0.4, 0.4, 0.8, 1 mg/kg, p.o. | Both sexes of white Wistar rats and NMRI | Not specified | No mortality | [62] |
Subchronic toxicity of Nigella sativa in animal studies
| Substance/dose | Animals used | Exposure period | Observation period | Main results | Reference |
|---|---|---|---|---|---|
| N. sativa seeds 20 and 100 g/kg, p.o. | 7-day-old Hibro broiler chicks | 7 weeks | Same 7 weeks | No toxicity | [55] |
Chronic toxicity of Nigella sativa in animal studies
| Substance/dose | Animals used | Exposure period | Observation period | Main results | Reference |
|---|---|---|---|---|---|
| N. sativa FO 2 mL/kg, p.o. | Wistar-Kyoto rats | 12 weeks | Same 12 weeks | ↓ Leukocyte and Plt | [49] |
| N. sativa FO 1 mL/kg, p.o. | Wistar-Kyoto rats | 12 weeks | Same 12 weeks | ↓ Leukocyte and Plt | [56] |
Nigella sativa toxicity in humans
| Substance | Concentration | Exposure route/period | Case history | Main results | Reference |
|---|---|---|---|---|---|
| Pure oil of black cumin | Not specified | Used on the neck for 3 months | 28-year-old man for treatment of sore throat | Allergic contact dermatitis | [60] |
| EO of the seeds of black cumin | Not specified | Repeatedly applied as an ointment | 31-year-old woman with an 8-month history of eczema on both hands | Allergic contact dermatitis | [61] |
| Capsules of BCEO | Containing 500 mg of organic N. sativa oil and 7.5 mg of vitamin E | Daily 15 days | 56-year-old woman | Severe bullous target-like lesions, compatible with erythema multiforme | [80] |